Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Transgene
Actym Therapeutics, Inc.
Washington University School of Medicine
Telix Pharmaceuticals (Innovations) Pty Limited
Hutchmed
Elevation Oncology
Mayo Clinic
NantCell, Inc.
Washington University School of Medicine
Pfizer
pharmaand GmbH
National Institutes of Health Clinical Center (CC)
MacroGenics
Seagen Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
Yale University
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
Pfizer
National Cancer Institute (NCI)
Emory University
Precision Therapeutics